Paraneoplastic disorders in thymoma patients

Journal of Thoracic Oncology

Volumn 9, Issue 9, 2014, Pages S143-S147

  Evoli, Amelia ^a   Lancaster, Eric ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Antibodies; Encephalitis; Isaacs' syndrome; Lambert eaton syndrome; Morvan's syndrome; Myasthenia gravis; Myositis; Neuromyotonia; Paraneoplastic; Thymic tumor; Thymoma; VGKC antibodies

Indexed keywords

CELL SURFACE PROTEIN;

ACQUIRED NEUROMYOTONIA; ARTICLE; AUTOIMMUNITY; CANCER SCREENING; DISEASE ASSOCIATION; EATON LAMBERT SYNDROME; ELECTROMYOGRAPHY; GENE REARRANGEMENT; HUMAN; IMMUNOLOGICAL TOLERANCE; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; MYOKYMIA; NEUROIMAGING; NEUROLOGIC DISEASE; NEUROMUSCULAR TRANSMISSION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANEOPLASTIC NEUROLOGICAL DISEASE; PATIENT CARE; PRIORITY JOURNAL; RECURRENT DISEASE; REGULATORY T LYMPHOCYTE; SEIZURE; THYMIC CORTEX; THYMOMA; PARANEOPLASTIC SYNDROMES, NERVOUS SYSTEM; PATHOLOGY;

HUMANS; PARANEOPLASTIC SYNDROMES, NERVOUS SYSTEM; THYMOMA;

EID: 84964312392     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0000000000000300     Document Type: Article

References (47)

1. Anderson NE, Cunningham JM, Posner JB. Autoimmune pathogenesis of paraneoplastic neurological syndromes. Crit Rev Neurobiol 1987;3: 245-299.
2. Rosenfeld MR, Dalmau JO. Paraneoplastic disorders of the CNS and autoimmune synaptic encephalitis. Continuum (Minneap Minn) 2012;18:366-383.
3. Marx A, Pfister F, Schalke B, Saruhan-Direskeneli G, Melms A, Ströbel P. The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes. Autoimmun Rev 2013;12:875-884.
4. Dzhagalov I, Phee H. How to find your way through the thymus: A practical guide for aspiring T cells. Cell Mol Life Sci 2012;69:663-682.
5. Gadalla SM, Rajan A, Pfeiffer R, et al. A population-based assessment of mortality and morbidity patterns among patients with thymoma. Int J Cancer 2011;128:2688-2694.
6. Meriggioli MN, Sanders DB. Muscle autoantibodies in myasthenia gravis: beyond diagnosis? Expert Rev Clin Immunol 2012;8:427-438.
7. Howard JF Jr. Electrodiagnosis of disorders of neuromuscular transmission. Phys Med Rehabil Clin N Am 2013;24:169-192.
8. Skeie GO, Apostolski S, Evoli A, et al. Guidelines for treatment of autoimmune neuromuscular transmission disorders. Eur J Neurol 2010;17:893-902.
9. Evoli A, Minisci C, Di Schino C, et al. Thymoma in patients with MG: characteristics and long-Term outcome. Neurology 2002;59:1844-1850.
10. Titulaer MJ, Lang B, Verschuuren JJ. Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies. Lancet Neurol 2011;10:1098-1107.
11. Engel AG, Nagel A, Fukuoka T, et al. Motor nerve terminal calcium channels in Lambert-Eaton myasthenic syndrome. Morphologic evidence for depletion and that the depletion is mediated by autoantibodies. Ann N Y Acad Sci 1989;560:278-290.
12. Waterman SA, Lang B, Newsom-Davis J. Effect of Lambert-Eaton myasthenic syndrome antibodies on autonomic neurons in the mouse. Ann Neurol 1997;42:147-156.
13. Kidher ES, Briceno N, Taghi A, Chukwuemeka A. An interesting collection of paraneoplastic syndromes in a patient with a malignant thymoma. BMJ Case Rep 3 July 2012.
14. Isaacs H. A syndrome of continuous muscle-fibre activity. J Neurol Neurosurg Psychiatry 1961;24:319-325.
15. Gutmann L, Gutmann L. Myokymia and neuromyotonia. J Neurol 2004;251:138-142.
16. Irani SR, Pettingill P, Kleopa KA, et al. Morvan syndrome: clinical and serological observations in 29 cases. Ann Neurol 2012;72:241-255.
17. Fleisher J, Richie M, Price R, Scherer S, Dalmau J, Lancaster E. Acquired neuromyotonia heralding recurrent thymoma in myasthenia gravis. JAMA Neurol. 2013;70:1311-1314.
18. Irani SR, Alexander S, Waters P, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-Associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain 2010;133:2734-2748.
19. Lai M, Huijbers MG, Lancaster E, et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: A case series. Lancet Neurol 2010;9:776-785.
20. Poliak S, Salomon D, Elhanany H, et al. Juxtaparanodal clustering of Shaker-like K+ channels in myelinated axons depends on Caspr2 and TAG-1. J Cell Biol 2003;162:1149-1160.
21. Abou-Zeid E, Boursoulian LJ, Metzer WS, Gundogdu B. Morvan syndrome: A case report and review of the literature. J Clin Neuromuscul Dis 2012;13:214-227.
22. Fukushima K, Sato T, Mitsuhashi S, et al. Isaacs' syndrome associated with myasthenia gravis, showing remission after cytoreductive surgery of pleural recurrence of thymoma. Neuromuscul Disord 2006;16:763-765.
23. Miyazaki Y, Hirayama M, Watanabe H, et al. Paraneoplastic encephalitis associated with myasthenia gravis and malignant thymoma. J Clin Neurosci 2012;19:336-338.
24. Dalmau J, Tüzün E, Wu HY, et al. Paraneoplastic anti-N-methyl-D-Aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007;61:25-36.
25. Lai M, Hughes EG, Peng X, et al. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol 2009;65:424-434.
26. Monstad SE, Nøstbakken JK, Vedeler CA. CRMP5 antibodies found in a patient with limbic encephalitis and myasthenia gravis. J Neurol Neurosurg Psychiatry 2009;80:241-242.
27. Erkmen CP, Fadul CE, Dalmau J, Erkmen K. Thymoma-Associated paraneoplastic encephalitis (TAPE): diagnosis and treatment of a potentially fatal condition. J Thorac Cardiovasc Surg 2011;141:e17-e20.
28. Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice- Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 2011;10:63-74.
29. Dell'Amore A, Asadi N, Caroli G, Dolci G, Bini A, Stella F. Paraneoplastic dermatomyositis as presentation of thymic carcinoma. Gen Thorac Cardiovasc Surg 2013;61:422-425.
30. Suzuki S, Utsugisawa K, Yoshikawa H, et al. Autoimmune targets of heart and skeletal muscles in myasthenia gravis. Arch Neurol 2009;66:1334-1338.
31. Kon T, Mori F, Tanji K, Miki Y, Kimura T, Wakabayashi K. Giant cell polymyositis and myocarditis associated with myasthenia gravis and thymoma. Neuropathology 2013;33:281-287.
32. Lancaster E, Huijbers MG, Bar V, et al. Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia. Ann Neurol 2011;69: 303-311.
33. Díaz-Manera J, Rojas-García R, Gallardo E, et al. Antibodies to AChR, MuSK and VGKC in a patient with myasthenia gravis and Morvan's syndrome. Nat Clin Pract Neurol 2007;3:405-410.
34. Uehara T, Murai H, Yamasaki R, et al. Thymoma-Associated progressive encephalomyelitis with rigidity and myoclonus successfully treated with thymectomy and intravenous immunoglobulin. Eur Neurol 2011;66: 328-330.
35. Clerinx K, Breban T, Schrooten M, et al. Progressive encephalomyelitis with rigidity and myoclonus: resolution after thymectomy. Neurology 2011;76:303-304.
36. Barua A, Gozzard P, Martin-Ucar AE, Maddison P. Neuronal antibodies and paraneoplastic sensory neuropathy in thymoma. Interact Cardiovasc Thorac Surg 2012;15:516-517.
37. Vernino S, Eggenberger ER, Rogers LR, Lennon VA. Paraneoplastic neurological autoimmunity associated with ANNA-1 autoantibody and thymoma. Neurology 2002;59:929-932.
38. Simonelli M, Banna GL, Santoro A. Thymoma associated with myasthenia and autonomic anti-Hu paraneoplastic neuropathy. Tumori 2009;95: 243-247.
39. Vernino S, Cheshire WP, Lennon VA. Myasthenia gravis with autoimmune autonomic neuropathy. Auton Neurosci 2001;88:187-192.
40. Barbetakis N, Samanidis G, Paliouras D, et al. Paraneoplastic pemphigus regression after thymoma resection. World J Surg Oncol 2008;6:83.
41. Qiao J, Zhou G, Ding Y, Zhu D, Fang H. Multiple paraneoplastic syndromes: myasthenia gravis, vitiligo, alopecia areata, and oral lichen planus associated with thymoma. J Neurol Sci 2011;308:177-179.
42. Agarwal S, Cunningham-Rundles C. Thymoma and immunodeficiency (Good syndrome): A report of 2 unusual cases and review of the literature. Ann Allergy Asthma Immunol 2007;98:185-190.
43. Aigner E, Strassburg CP, Strasser M, et al. Transient autoimmune hepatitis induced by a thymoma. Am J Gastroenterol 2009;104:1332-1334.
44. Yapali S, Oruc N, Ilgun S, et al. Acute presentation of autoimmune hepatitis in a patient with myasthenia gravis, thymoma, Hashimoto thyroiditis and connective tissue disorder. Hepatol Res 2012;42:835-839.
45. Dawson MA. Thymoma associated with pancytopenia and Hashimoto's thyroiditis. Am J Med 1972;52:406-410.
46. Wan CK, Teoh SC. Autoimmune retinopathy in benign thymoma after good syndrome-Associated cytomegalovirus retinitis. Ocul Immunol Inflamm 2013;21:79-81.
47. Titulaer MJ, Soffietti R, Dalmau J, et al. Screening for tumours in paraneoplastic syndromes: report of an EFNS task force. Eur J Neurol 2011;18:e19-e3.